Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biweekly Paclitaxel Plus Bevacizumab in Elderly Metastatic Breast Cancer
NCT01120158Phase 2Terminated
- Sponsor
- Hellenic Oncology Research Group
- Start
- Sep 2009
- Primary completion
- Jan 2017
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in breast cancer, sponsored by Hellenic Oncology Research Group. Started Sep 2009; status: terminated.
02
Drugs
bevacizumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01120158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01120158.